These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 4696099

  • 1. The effects of guanethidine, bretylium and debrisoquine on the accumulation of noradrenaline in constricted postganglionic sympathetic nerves in vitro.
    Tomlinson DR, Mayor D.
    Eur J Pharmacol; 1973 Feb; 21(2):161-70. PubMed ID: 4696099
    [No Abstract] [Full Text] [Related]

  • 2. Some factors affecting the neuron blocking action of guanethidine, xylocholine, bretylium and debrisoquin.
    Prasad CM, Shah DS, Gulati OD.
    Jpn J Pharmacol; 1973 Dec; 23(6):805-11. PubMed ID: 4544694
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.
    Thoenen H, Huerlimann A, Haefely W.
    J Pharmacol Exp Ther; 1966 Feb; 151(2):189-95. PubMed ID: 5932597
    [No Abstract] [Full Text] [Related]

  • 4. Effect of drugs on adrenergic nerve terminals.
    von Euler US.
    Adv Cytopharmacol; 1971 May; 1():363-7. PubMed ID: 4148190
    [No Abstract] [Full Text] [Related]

  • 5. Release of noradrenaline from sympathetic endings.
    Burn JH.
    Nature; 1971 May 28; 231(5300):237-40. PubMed ID: 4930688
    [No Abstract] [Full Text] [Related]

  • 6. The action of acetyl choline and other drugs upon the terminal parts of the postganglionic sympathetic fibre.
    Cabrera R, Torrance RW, Viveros H.
    Br J Pharmacol Chemother; 1966 May 28; 27(1):51-63. PubMed ID: 5961470
    [No Abstract] [Full Text] [Related]

  • 7. The effects of debrisoquin and bretylium on adrenergic nerves as revealed by fluorescence histochemistry.
    Malmors T, Abrams WB.
    J Pharmacol Exp Ther; 1970 Jul 28; 174(1):99-110. PubMed ID: 4316536
    [No Abstract] [Full Text] [Related]

  • 8. [On the mechanism of the adrenergic blocking action of bretylium and guanethidine].
    Haeusler G, Haefely W, Huerlimann A.
    Naunyn Schmiedebergs Arch Pharmakol; 1969 Jul 28; 264(3):241-3. PubMed ID: 4242393
    [No Abstract] [Full Text] [Related]

  • 9. [Ultrastructural modifications induced by several drugs on adrenergic nerve endings and on the adrenal medulla].
    Clementi F.
    Experientia; 1965 Mar 15; 21(3):171-6. PubMed ID: 5890429
    [No Abstract] [Full Text] [Related]

  • 10. Fate of norepinephrine in sympathetic nerons and by cardiovascular drugs.
    Axelrod J, Wurtman RJ.
    N Y State J Med; 1968 Jan 15; 68(2):252-6. PubMed ID: 4383958
    [No Abstract] [Full Text] [Related]

  • 11. [Drugs with effect on the adrenergic nerve fiber].
    Haefely W.
    Pharm Acta Helv; 1968 Dec 15; 43(12):757-75. PubMed ID: 4886667
    [No Abstract] [Full Text] [Related]

  • 12. Effects of bretylium, guanethidine and bethanidine on the cat's pad sweat glands.
    Foster KG.
    J Physiol; 1967 May 15; 190(2):21P. PubMed ID: 4292798
    [No Abstract] [Full Text] [Related]

  • 13. Interactions of bretylium and acetylcholine at sympathetic nerve endings.
    Fischer JE, Weise VK, Kopin IJ.
    J Pharmacol Exp Ther; 1966 Sep 15; 153(3):523-9. PubMed ID: 5921529
    [No Abstract] [Full Text] [Related]

  • 14. 3 H-noradrenaline-accumulating ability of cholinergic nerve terminals in cat sympathetic ganglia.
    Graham JD, Ivens C, Lever JD, Joó F, Mottram DR, Spriggs TL.
    Br J Pharmacol; 1971 Nov 15; 43(3):555-9. PubMed ID: 5157722
    [Abstract] [Full Text] [Related]

  • 15. The relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives.
    Abbs ET, Dodd MG.
    Br J Pharmacol; 1974 Jun 15; 51(2):237-47. PubMed ID: 4451743
    [Abstract] [Full Text] [Related]

  • 16. The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine.
    Abrams WB, Solomon HM.
    Clin Pharmacol Ther; 1969 Jun 15; 10(5):702-9. PubMed ID: 4390109
    [No Abstract] [Full Text] [Related]

  • 17. Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.
    HERTTING G, AXELROD J, PATRICK RW.
    Br J Pharmacol Chemother; 1962 Feb 15; 18(1):161-6. PubMed ID: 14036196
    [Abstract] [Full Text] [Related]

  • 18. Maintenance of noradrenaline in neuronal cell bodies and terminals: effect of frequency of stimulation.
    Bhatnagar RK, Moore KE.
    J Pharm Pharmacol; 1971 Aug 15; 23(8):625-7. PubMed ID: 4397749
    [No Abstract] [Full Text] [Related]

  • 19. Peripheral noradrenaline and adrenergic transmission in the rat.
    Spriggs TL.
    Br J Pharmacol Chemother; 1966 Jan 15; 26(1):271-81. PubMed ID: 5919511
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological implications of the fate of noradrenaline in the artery wall.
    De la Lande IS, Hodge RL, Lazner M, Jellett LB, Waterson JG.
    Circ Res; 1970 Oct 15; 27():Suppl 2:41-8. PubMed ID: 5506147
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.